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Fluorescence microscopy is a powerful analytical tool for visualizing biological 
processes at the subcellular level. In this regard, 1,3,5-triarylpyrazoline based fluorescent 
probes which act as “turn-on” probes, have been extensively researched. These probes 
achieve their fluorescence “turn-on” response by inhibition of fluorescence quenching by 
acceptor-excited photoinduced electron transfer upon binding of an analyte. It has been 
recently shown that some fluorescent probes used in biological research form colloids 
composed of nanoparticles, due to their hydrophobic character. This hydrophobic 
character can also lead to partitioning of the probe into cellular membranes. Colloid 
formation and membrane partitioning may affect the probes’ photophysical properties 
such as absorption and emission wavelength and quantum yields. Recently, a series of 
1,3,5-triarylpyrazolines synthesized in our group by M. T. Morgan, showed no formation 
of aggregates in aqueous buffer. Surprisingly, these probes increased their fluorescence 
intensity in the presence of liposomes. The photoinduced electron transfer process is 
greatly affected by the polarity of the medium in which the probe is used. In this study, 
the effect of membrane proximity on the photoinduced electron transfer process for 
pyrazoline based “turn-on” probes has been investigated. A series of water soluble 1,3,5-
triarylpyrazolines have been synthesized in which a N,N-dialkylaniline moiety acts as an 
electron donor and a proton acceptor and an alkylated sulfonamide moiety acts as a 






 Transition metals are essential for sustaining all forms of life. 
Approximately one third of all known proteins contain one or more metal cations in their 
active site.
1
 To ensure proper maintenance of this metal ion pool at the cellular level, 
nature has developed sophisticated regulatory mechanisms that involve a complex 
interplay of DNA with proteins and other biomolecules.
2
 Over the past decade, metal 
dyshomeostasis has been associated with a growing number of diseases, including the 
genetic disorders Wilson‟s disease
3
 and Menkes syndrome
4
 and the neurodegenerative 
diseases Alzheimer‟s disease
5
 and Parkinson‟s disease
6
. While some progress has been 
made towards understanding the molecular basis of these disorders, many important 
questions remain unanswered. For example, little is known about the regulatory 
mechanisms involved in metal ion transport, storage, and trafficking or about the 
recycling pathways of metal ions upon protein degradation. A better understanding of 
these processes is critical to create new ways of treating disorders related to metal 
dyshomeostasis.  
There are currently several highly sensitive micro-analytical techniques and 
instruments available for the in situ detection of metal ions.
2a
 For example, laser ablation-
inductively coupled plasma-mass spectrometry (LA-ICP-MS) and synchrotron X-ray 
fluorescence (SXRF) can provide quantitative topographical maps of trace metals. These 
methods, however, are not suitable for continuous imaging of live cells due to their use of 
high-energy ion beams and ionizing x-rays, respectively. In contrast, fluorescence 
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microscopy represents a powerful and noninvasive analytical tool, which under favorable 
conditions, and depending on the brightness of the fluorescent probe, is capable of 
visualizing biological processes even at the single molecule level.
7
 It is important to note 
that metal cations are not inherently fluorescent. At present, fluorescent probes have been 















 and for monitoring differences 
in intracellular pH levels.
8
 Depending on their fluorescence response upon binding of the 
analyte, the probes can be grouped into two classes: ratiometric probes which undergo a 
spectral shift of the excitation or emission wavelength, and “turn-on” probes which 
respond with a change in fluorescence intensity.  
Fluorescent probes designed for biological research must maintain a balance 
between hydrophilicity and hydrophobicity. If the probe is too hydrophilic, it may not 
passively diffuse through the lipid bilayer membrane of the targeted cell. On the other 
hand, if the probe is too hydrophobic, it may either partition into the lipid membrane or 
form aggregates. Both phenomena have dramatic effects on the photophysical properties 
of the fluorescent probes. 
 
1.2 Fundamental concepts of fluorescence 
In order for fluorescence to occur, a fluorophore must first absorb a photon, which 
results in promotion of an electron from an occupied molecular orbital, typically the 
highest occupied molecular orbital, HOMO, to an unoccupied molecular orbital, typically 
the lowest unoccupied molecular orbital, LUMO, (Figure 1.1a).
9
 Upon excitation the 
fluorophore arrives at a vibrationally excited state of the first excited electronic sate, (S1). 
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After rapid relaxation to the vibrational ground state of the first excited electronic state, 
the molecule returns to the electronic ground state, (GS), while simultaneously emitting a 
photon, (Figure 1.1b).
9
 It is important to note that the emitted photon is lower in energy 
compared to the absorbed photon due to energy loss during the vibrational relaxation 
process. In addition, the excited state can undergo several non-radiative processes such as 
internal conversion or intersystem crossing (Figure 1.1b).
9
 The ratio between the rate 
constant of the radiative process (kr) and the rate constants of all radiative and non-
radiative processes (kr + knr) corresponds to the quantum yield,    
  
      
 . The 
quantum yield could be regarded as the fluorescence efficiency. If the non-radiative 
process is faster than the radiative process, then the radiative process is less likely to 
occur, resulting in fluorescence quenching and a reduced quantum yield.  
 
Figure 1.1: Photo-excitation of a fluorophore. a) orbital energy diagram, b) Jablonski diagram. 
GS = ground state, S1 = first excited singlet state, IC = internal conversion, kr = radiative rate constant, knr = 
non-radiative rate constant. 
 
The fluorescence response of fluorescent probes is modulated through several 
different mechanisms, including (n-π*)/(π-π*) excited state inversion, photoinduced 





1.3 Acceptor-excited photoinduced electron transfer and 1,3,5-triarylpyrazolines 
A large class of cation responsive fluorescence “turn-on” probes utilizes acceptor-
excited photoinduced electron transfer (PET) as a quenching mechanism to modulate the 
fluorescence emission.
9
 Upon excitation, the fluorophore (A*) is rendered a strong 
oxidant, and in proximity of a suitable donor/receptor moiety (D), an electron transfer 




). This radical ion pair 
typically undergoes a rapid non-radiative charge recombination with rate constant kcr 
back to the ground state, (Figure 1,2a).
9
 As a result, PET quenches the fluorescence and 
decreases the quantum yield. If the electron donor moiety is protonated or a metal cation 
is coordinated to it, the PET process is rendered thermodynamically less favorable, 
resulting in an increase of fluorescence intensity and quantum yield (Figure 1.2b). 
Because the analyte interacts directly with the donor/receptor moiety and not with the 






Figure 1.2: Photoinduced electron transfer switching mechanism. a) In the absence of the analyte, electron 
transfer from the donor D to the excited fluorophore A
*
 is thermodynamically favorable. The rate of 
electron transfer ket is faster than the rate for the radiative process, kr, resulting in emission quenching. b) 
Analyte coordination to the electron donor D decreases the driving force for PET, and slows down the 
electron transfer process. The radiative process favorably competes with PET, and the fluorescence is 
turned on. GS = groundstate, ET = electron transfer state. 
 
 
To create a fluorescence “turn-on” probe which takes advantage of PET, one must 
ensure that the fluorescence properties of the probe will not change due to an analyte-
mediated quenching pathway. This quenching pathway commonly occurs with redox-
active cations such as Cu(I) in the case of bathocuproine disulfonate (BSC)
10
. This can be 
achieved by electronically decoupling the analyte binding moiety from the fluorophore 
by introducing a spacer between them. In this regard, 1,3,5-triarylpyrazolines have been 
extensively studied due to their unique electronic structure shown in Figure 1.3.
11
 As 
illustrated with the orbital density plots of the 1,3,5-triphenylpyrazoline, the HOMO is 
located in the 1-aryl ring and the LUMO is located on the 3-aryl ring, which means that 
the fluorophore moiety is composed of the conjugated  π system containing the 1-aryl 
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ring and the 3-aryl ring. The 5-aryl ring is electronically decoupled from the 1- and 3-aryl 
rings by an sp
3
 hybridized carbon.  
 
 
Figure 1.3: Photoinduced electron transfer probes based on 1,3,5-triarylpyrazoline fluorophores. Left: 
molecular architecture. Right: HOMO (left) and LUMO (right) densities of 1,3,5-triphenylpyrazoline. 
 
In absence of the analyte, the PET quenching process must be a spontaneous 
process for a probe to act as a “turn-on” probe, therefore, the electron transfer process 








/A) – ΔE00 + wp (1.1) 




/A) represent the 
donor and acceptor ground state reduction potentials respectively. ΔE00 is the excited 
state equilibrium energy, and wp is the Coulomb stabilization energy associated with the 
intermediate radical ion pair. Because the HOMO and the LUMO densities of 1,3,5-
triarylpyrazoline fluorophores are unequally distributed with regard to the two 1- and 3-
aryl substituents, it is possible to adjust  ΔE00 without significantly altering E(A
-
/A) and 
vice versa. More specifically, an electron withdrawing substituent on the 1-aryl ring 
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preferentially lowers the HOMO energy, and thus increases ΔE00, while an electron 




A very important factor affecting ΔGet is the polarity of the medium in which the 





) from the neutral excited state (A
*
-D). The oxidation potential of 
the donor and reduction potential of the acceptor along with the work term, wp may 
change dramatically when switching from a polar to a non-polar solvent. In a non-polar 
solvent the oxidation potential will become more positive and the reduction potential will 
become more negative (compared to a polar environment), requiring more energy to 
remove an electron from the donor moiety and more energy to add an electron to the 
acceptor moiety. On the other hand, the work term contribution to the free energy change 
will increase in a non-polar solvent. This increase is typically not sufficient so to 
compensate for the less favorable potentials. Therefore, to optimize the contrast between 
the free and analyte bound form of a probe, ΔGet must be specifically tuned with regard to 
the polarity of the surrounding medium (solvent). This is of vital importance because 
most fluorescent probes used in biological research are lipophilic and tend to form 
aggregates in aqueous media or partition into the phospholipid bilayer membrane. 
 
1.4 Aggregation and membrane partitioning of fluorescent probes 
Fluorescent probes must be sufficiently hydrophilic to dissolve in biological 





. If a fluorescent probe is too lipophilic it will partition into the lipid 
bilayer or aggregate in aqueous solution, both of which may dramatically alter the 
photophysical properties including, quantum yield, absorption and emission 
wavelengths
13
. For example, boron dipyrromethene (BODIPY) fluorescent probes tend to 
form J and H aggregates in polar solvent that exhibit dramatically different photophysical 
properties compared to their non-aggregated forms.
14
 Even BODIPY probes which were 
functionalized with water solubilizing groups showed a dramatic increase in quantum 
yield when an organic co-solvent (DMSO) was added to an aqueous solution of the dye.
15
 
Because most fluorescent probes used in biological research are lipophilic and 
poorly water soluble, a very common procedure of applying them to cells is to create a 
DMSO stock solution and dilute it into the aqueous buffer to achieve a final probe 
concentration in the low micromolar range. A recent study conducted in our group by 
Morgan et al.
16
, showed that this approach did produce optically clear solutions, but those 
solutions contained nanoparticles of sizes below the diffraction limit, as indicated by 
dynamic light scattering experiments (Table 1.1).  Although formation of such colloidal 
aggregates might not necessarily invalidate the biological studies utilizing these probes, 
the photophysical properties of the colloid may be dramatically different compared to 
those of the monomeric form. The cellular environment is likely to induce a shift in the 
equilibrium between the aggregated and monomeric forms of the probe. Hence, when 
using fluorescent probes in the mixed polarity of the cell, one must practice caution when 





Table 1.1: Colloid formation of Cu(I)-selective 
fluorescent  probes in aqueous buffer (10 mM 
MOPS/K
+
, pH 7.2, 25° C)
a
 




























DMSO stock solution (1 mM) of the probe diluted into 








Figure 1.4: Previously published Cu(I)-selective fluorescence probes.
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The probes shown in Figure 1.4 were functionalized with a thioether crown to 
selectively bind Cu(I). This thioether crown further increases their lipophilic character. 
While probes 1, CS1 and CS3 have no water solubilizing functional groups to mitigate 
their lipophilicity, CTAP-1 has been functionalized with a carboxylic acid on its 1-aryl 
ring. Surprisingly, dynamic light scattering experiments revealed that CTAP-1 still forms 
aggregates. 
A series of triarylpyrazolines, utilizing acceptor excited photoinduced electron 
transfer as a quenching mechanism for modulating fluorescence response, were 
10 
 
synthesized by Morgan et al. (Figure 1.5). When dissolved in aqueous buffer, these 
compounds produced aggregate-free solutions; however, in the presence of liposomes a 
significant increase in fluorescence intensity was observed. This unexpected observation 
suggests that the hydrophilic probes still interact with the lipophilic environment of the 
lipid bilayer, which in turn renders the PET process thermodynamically less favorable, 
resulting in increase of quantum yield. 
 
 
Figure 1.5: Structures of 1,3,5-triarylpyrazolines that do not aggregate, but in presence of liposomes show 
a significant increase in fluorescence intensity. 
 
Based on the dynamic light scattering experiments, it is likely that probes 1, CS1 
and CS3 exhibit sufficient lipophilic character to become completely embedded in the 
phospholipid bilayer of the liposome. It was expected that the anionic charge on the 1-
aryl ring on CTAP-1 would cause some repulsion between the aryl ring and the 
phospholipid head groups in the lipid bilayer. Nevertheless, the 3- and 5-aryl rings appear 
to be sufficiently lipophilic to partition within the membrane. In the case of CTAP-2, 
interaction with the lipid bilayer is expected to be reduced compared to the other more 
lipophilic probes due to the presence of water solubilizing groups on the thioether crown 
11 
 
and the 1-aryl ring. Still, the 3-aryl ring and its nitrile substituent along with the carbon 
framework that constitutes the spacer between the fluorophore and the thioether crown 
are lipophilic enough to promote membrane interactions throughout that region of the 
molecule. Because the interaction of the probes with the lipid bilayer is not well defined, 
it is nearly impossible to estimate the effect of membrane proximity on the kinetics of the 
PET process. Because a decrease in the PET kinetics results in a quantum yield increase, 
the photophysical properties provide a direct readout to gauge changes in the PET 
kinetics. 
A study on characterizing, in a well-defined manner, the effect of phospholipid 
bilayer membrane proximity on 1,3,5-triarlypyrazoline-based fluorescence “turn-on” 
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SYNTHESIS AND CHARACTERIZATION OF NEW WATER-
SOLUBLE 1,3,5-TRIARLYPYRAZOLINE BASED FLUORESCENT 
PROBES 
2.1 Introduction 
To systematically characterize the proximity effect of a lipid bilayer on 
photoinduced electron transfer (PET) based probes, a series of water-soluble 1,3,5-
triarylpyrazoline derivatives 9-11 with varying degrees of lipophilicity were synthesized. 
A metal ion receptor might potentially complicate the fluorescence quenching behavior, 
through formation of ternary complexes with solvent molecules as recently demonstrated 
by Chaudhry et al.
1
 Therefore, a simple N,N-dialkylaniline moiety was chosen as a 
representative electron donor and proton acceptor to modulate PET (Figure 2.1). Water 
solubility was achieved by attaching a sulfonic acid group to the 1-aryl ring and by 
functionalizing the 3- and 5-aryl rings with a total of three carboxylic acid groups. To 
tune the lipophilicity and degree of membrane association, the sulfonamide moiety of the 





Figure 2.1: Structure of 1,3,5 triarylpyrazolines 9-11. 
 
 
As mentioned in the previous chapter, the 5-aryl ring of 1,3,5-triarylpyrazolines is 
electronically decoupled from the fluorophore and can act as a donor/receptor moiety. 
Upon protonation, the donor potential of the aniline moiety increases, thus resulting in a 
thermodynamically less favorable PET process. By positioning the alkyl-chain at the 3-
aryl sulfonamide group, the interaction with the lipid biplayer can be expected to occur in 
a well-defined manner. Furthermore, anionic water-solubilizing groups were distributed 
throughout the pyrazoline skeleton to avoid membrane association with other regions of 
the pyrazoline framework as indicated in Chapter 1 for CTAP-1 and CTAP-2.  
 
2.2 Synthesis 
The first report on the synthesis of 1,3,5-triarylpyrazolines dates back more than a 
century.
2
 Since then, the pyrazoline core has been commonly constructed by 
condensation of a chalcone and phenylhydrazine derivative carrying the corresponding 
substituents.
1, 3
 The synthesis in this work followed accordingly; the key intermediate in 
the synthesis of derivatives 9-11 was chalcone 4, which was obtained by a Claisen-
18 
 
Schmidt condensation of aldehyde 2 and acetophenone derivative 3, (Scheme 2.1). To 
minimize the undesired Michael addition between the formed chalcone and unreacted 
starting material, aldehyde 2 was used with a two-fold excess. Aldehyde 2 was obtained 
in 70% overall yield, starting from unsubstituted aniline that was subjected to a double 
Michael addition with excess ethyl acrylate, and followed by Vilsmeier-Haack 
formylation with phosphoryl chloride in dimethyl formamide. The acetophenone 
derivative 3 was readily accessible by coupling of ethyl glycinate with commercially 
available 4-acetylbenzenesulfonyl chloride. 
 
Scheme 2.1: Synthesis of chalcone 4. 
 
To construct the pyrazoline core, chalcone 4 was reacted with the corresponding 
protected arylhydrazine
1, 3a, b
 (Scheme 2.2). Some cleavage of the acetonide moiety was 
observed, most likely due to the acidic reaction conditions. For this reason, the crude 





Scheme 2.2: Synthesis of the 1,3,5-triarylpyrazoline core. 
 
For the synthesis of derivatives 6-8, the fully protected pyrazoline 5 was alkylated 
at the sulfonamide nitrogen with a range of alkyl bromides of different chain lengths 
(Scheme 2.3a), followed by hydrolysis under acidic conditions to give the corresponding 
diol derivatives. It was anticipated that both hydrolysis of the ester groups as well as 
deprotection of the sulfonic acid would occur under strongly basic conditions, as the 
mono-deprotonted diol could undergo an intramolecular ring closure to form the 
corresponding oxetane and release the sulfonate moiety as illustarted with Scheme 2.3b. 
The first attempt to remove the neopentyl protective group and hydrolyze all esters with 
potassium hydroxide produced the final pyrazoline derivatives after 3 days. This long 





Scheme 2.3: Synthesis of 1,3,5-triarylpyrazoline derivatives 9-11. a. Synthetic scheme. b. Proposed 
mechanism for removal of neopentyl protective group. 
 
After HPLC purification of the final products, the 
1
H-NMR spectra revealed unexpected 
impurities in the aromatic region (6 to 8ppm). It is well-known that pyrazolines are 
susceptible towards photo-oxidation to produce the corresponding pyrazoles as outlined 
in Figure 2.2. For example Rivett et al
4
. showed that irradiation of 1,3,5-
triarylpyrazolines at wavelengths ranging between 370-380 nm led to 50% conversion of 
the pyrazolines to the corresponding photo-oxidized pyrazoles within an average of 90 
minutes. The pyrazole formation was readily identified based on the characteristic singlet 








Figure 2.2: Photo-oxidation of 1,3,5-triarylpyrazolines to the corresponding pyrazoles. 
 
To improve the overall yield and purity of the product, the reaction conditions 
were further optimized by limiting exposure to light and utilizing a stronger base to favor 
a faster deprotection. As previously reported, the neopentyl diol intermediate can be 
effectively removed by potassium tert-butoxide in tetrahydrofuran (THF),
3e
 which is 
poorly solvated in this solvent and therefore much more basic compared to aqueous 
solutions. The reaction with potassium tert-butoxide in THF was indeed much faster 
compared to potassium hydroxide and after 15 minutes most of the starting material was 
converted to the sulfonate product. After hydrolysis of the esters and purification via 
HPLC, 
1
H-NMR analysis showed that presumably intermediate 13 was formed rather 
than the desired product (as the ammonium salt). Because the sulfonamide moiety is 
separated by only one carbon from the electron withdrawing carboxyl group, the glycyl 





Scheme 2.4: Proposed mechanism for the cleavage of the carboxymethyl sulfonamide functionality. 
 
Since secondary sulfonamides can be readily deprotonated
5
 to render them less 
susceptible for the proposed cleavage mechanism, the protective groups were removed 
prior to alkylation of the sulfonamide; however, the latter conversion produced the 
desired product in only 0.5% yield, (Scheme 2.5). The low yield is most likely due to 






Scheme 2.5: Alkylation of the hydrolyzed pyrazoline intermediate under biphasic reaction conditions. 
 
Based on these unsuccessful attempts, the initially used reaction conditions were re-
evaluated. This time, the deprotection was carried out under strict exclusion of oxygen 
and protection from light, producing now the final desired products with 29% to 63% 
yield. 
 
2.3 Photophysical characterization 
 To gauge the effect of membrane proximity on the PET process, the HPLC-
purified 1,3,5-triarylpyrazolines 9-11 were first characterized in neat aqueous buffer 
solution (Table 2.1). For all derivatives, the absorption and emission maxima were 
determined in 10 mM MOPS buffer (pH 8.5). To determine the pKa value of the aniline 
nitrogen, compound 9 was subjected to a spectrophotometric potentiometric titration in 





Table 2.1: Photophysical characterization of 1,3,5-triarlypyrazolines 9-11 
    λ (nm)   ΦF
b
   
Compound
a









9 CH3 382 504 5.96 0.2698 0.0013 207 
10 C8H17 386 495 
  
0.0011 




 Fluorescence quantum yield (norharmane in 0.1 N H2SO4 as reference). 
c
pKa titration was done in 1 mM PIPES, 1 mM PIPBS 0.1M KCl (pH 8.5) as described in the 








, pH 11. 
f
fluorescence enhancement factor calculated as the ratio between the acid and basic quantum 
yields. abs = absorption, em = emission. 
  
This pKa value served as an important reference point to ensure that the quantum yields 
of the protonated and deprotonated forms (acquired at a pH 4 and 8.5, respectively) were 
only of a single species. Because compounds 10 and 11 were expected to have very 
similar pKa values, the potentiometric titration was only carried out with compound 9. 
Protonation of compound 9 induced a 207-fold increase in fluorescence. As shown in 
Table 2.1, all three compounds were found to have similar quantum yields under basic 
conditions at pH 11. Furthermore, the absorption and emission wavelengths were slightly 
affected by the alkyl chain lengths. While the absorption wavelength increased with 
increasing the alkyl chain length, the emission wavelength showed the opposite trend. It 
is noteworthy that the same effects on absorption and emission wavelengths were 
observed for the sulfonated pyrazoline derivative CTAP-2 upon changing the solvent 





2.4 Cellular permeability  
To test whether pyrazolines 9-11 might passively diffuse across the plasma 
membrane of mammalian cells, adherent NIH 3T3 cells were cultured in DMEM and 
incubated for 1 hour with 5 µM of each dye followed by fluorescence microscopy 
imaging. As shown in Figure 2.3, the cells are only weakly fluorescent compared to the 
background fluorescence of control cells that were not incubated with any compound, 
making it difficult to assess the degree of membrane permeability. 
Figure 2.3: Fluorescent micrographs of NIH 3T3 cells incubated for an hour with 5 μM probe (final conc.) 
in DMEM at pH=7.2. Panel 9 represents cells incubated with compound 9, panel 10 represents cells 
incubated with compound 10, panel 11 represents cells incubated with compound 11 and panel control 
represents cells incubated with DMEM. 
 
2.5 Material and methods 
General: 4-Acetylbenzenesulfonylchloride (Fluka analytical), glycine ethylester 
hydrochloride (Sigma Aldrich), aniline (Alfa Aesar) and ethylacrylate (Acros organics), 
were commercially available. NM : δ in ppm using SiMe4 as a reference (0 ppm, 1H, 
400 MHz). MS: selected peaks; m/z. Flash chromatography: Merck silica gel (70-230 
mesh). TLC: 0.25 mm, Merck silica gel 60 F254, spots were visualized under 254 nm 
UV. Reversed phase HPLC was conducted with a 30 x 1 cm R-18 column at ambient 
temperature using an elution gradient of 0%-40% MeCN/0.1% aqueous NH4HCO3 over 
80 minutes. The eluted products were freed of NH4HCO3 by repeated dissolution in 
methanol followed by evaporation under vacuum. 
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2.5.1 Synthesis of chalcone 4 
 
Scheme 2.6: Synthesis of intermediate 4. 
 
Ethyl 2-(4-acetylphenylsulfonamideo)acetate (1) 
4-acetylbenzenesulfonylchloride (2.6 g, 0.019 mol) was dissolved in 6.0 mL of 
anhydrous pyridine and added slowly to a solution of glycine ethylester hydrochloride 
(3.44 g, 1.3 eq) in 4.0 mL of anhydrous pyridine. The combined mixture was stirred for 1 
h under N2 at room temperature. A color change, from yellow to red, was noticed over a 
period of 1 h. After addition of crushed ice the solution was diluted in H2O (80 mL). The 
white crystalline product was filtered off and dried under vacuum. Yield: 2.77 g (51%). 
1
H NMR (CDCl3, 400 MHz) δ 1.19 (t, J = 7.12 Hz, 3H), 2.65 (s, 3H), 3.82 (d, J = 5.36 
Hz, 2H), 4.10 (q, J = 7.15, 2H), 5.18 (t br, J = 5.27 Hz, 1H), 7.97 (dt, J = 8.64, 1.9 Hz, 
2H), 8.10 (dt, J = 8.71, 1.9 Hz, 2H). 
13
C NMR (CDCl3, 400 MHz) δ 13.94, 26.83, 44.09, 
62.01, 140.15, 143.25, 168.55, 196.70. EI HRMS m/z calculated for [M
+
] C12H15NO5S 






Freshly distilled aniline (4.08 g, 0.044 mol) was dissolved in 7.0 mL hexafluoro-2-
propanol along with 14.0 mL ethylacrylate (13.16 g, 3 eq). Solution was stirred at 75 °C 
for 137 hours. Reaction was concentrated under vacuum. Product was purified by column 
chromatography (10:1 hexanes ethyl acetate) yielding a mixture of di-substituted and 
mono-substituted products (5:1), (83% di-substitution). 
1
H NMR (CDCl3, 400 MHz) δ 
1.25 (t, J = 7.14 Hz, H), 2.58 (t br,J = 7.34, 7.24 Hz, 4H), 3.66 (t br, J = 7.34, 7.24 Hz, 
4H), 4.14 (q, J = 7.15Hz, 4H), 6.70-6.74 (m, 3H), 7.22-7.26 (m, 2H). 
13
C NMR (CDCl3, 
400 MHz) δ 14.18, 32.49, 46.85, 60.57, 112.58, 116.97, 129.45, 146.76, 172.09. EI 
HRMS m/z calculated for [M
+
] C16H23NO4 293.1627, found 293.1630. 
 
Diethyl 3,3'-((4-formylphenyl)azanediyl)dipropanoate (3) 
Dimethylformamide (5.5 mL, 70.92 mmol) was cooled in an ice bath, and POCl3 (3.5 
mL, 35.5 mmol) was added drop wise. The resulting mixture was added to a solution of 
ethyl 2-(4-acetylphenylsulfonamideo) acetate ( 1.1516 g, 3.94 mmol) in DMF (1.0 mL). 
After stirring for 80 minutes at 75 °C the mixture was cooled to room temperature, 
poured into water (20 mL), and made basic with 35.5 mL of 20% NaOH. The mixture 
was extracted with methyl tert-butyl ether (MTBE, 2 x 20 mL). The combined organic 
extracts were dried over dried over Na2SO4 and concentrated under reduced pressure to 
give the product as yellow oil. Yield: 0.9282 g (73%). 
1
H NMR (CDCl3, 400 MHz) δ 
1.26 (t, J = 7.18 Hz, 6H), 2.63 (t, J = 7.23 Hz, 4H), 3.77 (t, J = 7.29 Hz, 4H), 4.15 (q, J = 





(CDCl3, 400 MHz) δ 14.10, 32.24, 45.60, 60.82, 111.20, 125.87, 132.18, 151.39, 171.41, 
190.12. EI HRMS m/z calculated for [M
+




Aldehyde 3 (480 mg, 1.493 mmol) and ethyl 2-(4-acetylphenylsulfonamideo)acetate (212 
mg, 0.746 mmol 0.5 equiv) were dissolved in 2.97 mL of ethanol. Pyrrolidine (184 µL, 
1.5 equiv) was then added, the reaction flask was sealed and the mixture was stirred for 3 
hours. The mixture was diluted with 10.0 mL H2O and 1.0 M mono sodium phosphate 
(2.0 mL) and extracted with ethyl acetate (2 x 20 mL). The combined organic extracts 
were dried over Na2SO4 concentrated under reduced pressure to give crude dark red oil. 
Product was purified by column chromatography (1:1 hexanes ethyl acetate) to give 
orange oil. Yield 382 mg (87%), aldehyde 2 was recovered in the same conditions (66%). 
1
H NMR (CDCl3, 400 MHz) δ 1.19 (t, J = 7.13 Hz, 3H), 1.26 (t, J = 7.16 Hz, 6H), 2.62 (t, 
J = 7.19 Hz, 4H), 3.75 (t, J = 7.25 Hz, 4H), 3.82 (d, J = 5.41 Hz, 2H), 4.10 (q, J = 7.02 
Hz, 2H), 4.16 (q, J = 7.02 Hz, 4H), 5.15 (t, J = 5.39 Hz, 1H), 6.715 (d, J = 9.41 Hz, 2H), 
7.26 (d, J = 15.66 Hz, 1H), 7.55 (d, J = 9.21 Hz, 2H), 7.78 (d, J = 15.66 Hz, 1H), 7.98 (d, 
J = 8.65 Hz, 2H), 8.08 (d, J = 8.65 Hz, 2H). 
13
C NMR (CDCl3, 400 MHz) δ 13.99, 14.17, 
32.38, 44.16, 46.63, 60.85, 62.02, 111.98, 116.63, 122.85, 127.36, 128.90, 131.06, 
142.14, 142.64, 147.04, 149.18, 168.63, 171.65, 189.34. EI HRMS m/z calculated for 
[M
+





2.5.2 Synthesis of alkylated protected pyrazoline derivatives 6-8 





A mixture of chalcone 4, (682 mg, 1.15 mmol), (2,2,5-trimethyl-1,3-dioxan-5-yl)methyl 
4-hydrazinylbenzenesulfonate (575 mg, 1.72 mmol) and pyridinium p-toluene sulfonate 
(291 mg, 1.15 mmol) in 2.0 mL pyridine was stirred in a sealed flask under N2 at 93 °C 
for 30 hours. After cooling to room temperature, the reaction mixture was diluted in 10 
mL dichloromethane followed by 10 mL xylenes and concentrated under reduced 
pressure. The residue was taken up in acetone (20 mL). Acetone diethylacetal (7.0 mL) 
was added followed by p-toluenesulfonic acid monohydrate (800 mg, 4 equiv.), and the 
mixture was stirred for 1 hour at room temperature. It was then made basic with 20% 
aqueous ammonia (1 mL), poured into water (140 mL) with brine (5 mL), and extracted 
with dichloromethane (3 x 35 mL). The combined extracts were dried with Na2SO4, 
concentrated under reduced pressure, and subjected to sequential column chromatography 
with hexanes-ethyl acetate (1:1) followed by pure dichloromethane to give the product as 
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a yellow glassy solid. Yield 848 mg (0.941 mmol, 81.8%).
1
H NMR (CDCl3, 400 MHz) δ 
0.82 (s, 3H), 1.18-1.25 (m, 12H), 1.37 (s, 3H), 2.55 (t, J = 7.31 Hz, 4H), 3.18 (dd, J = 
17.11, 5.7 Hz, 1H), 3.55, (s, 4H), 3.63 (t br, J = 7.21 Hz, 4H), 3.81 (d, J = 5.50 Hz, 2H), 
3.85 (dd, J = 5.39 , 1H), 4.04 (s, 2H), 4.08-4.14 (m, 6H), 5.12 (t, J = 5.41), 5.35 (dd, J = 
6.22, 5.68 Hz, 1H), 6.64 (d, J = 9.06 Hz, 2H), 7.07 (d, J = 9.06 Hz, 2H), 7.17 (d, J = 9.06 
Hz, 2H), 7.70 (d, J = 9.26 Hz, 2H), 7.84 (dd, J=8.72, 2H), 7.89 (dd, J = 8.79, 2H).
13
C 
NMR (CDCl3, 400 MHz) δ 13.94, 14.09, 17.21, 19.49, 27.43, 32.33, 33.81, 44.07, 46.61, 
60.56, 61.91, 63.40, 65.58, 65.64, 72.06, 97.94, 112.75, 112.91, 124.13, 126.34, 126.73, 
127.51, 128.22, 129.50, 136.44, 138.99, 146.56, 147.43, 147.74, 168.62, 171.81. EI 
HRMS m/z calculated for [M
+





A mixture of Pyrazoline 5 (200 mg, 0.222 mmol), iodomethane (35 µL, 0.555 mmol) and 
potassium carbonate (61.5 mg, 0.444 mmol) in 1.0 mL anhydrous acetonitrile was stirred 
in a sealed flask under N2 room temperature for 4 hours. Potassium carbonate (92 mg, 
0.666 mmol) and iodomethane (35 µL, 0.555 mmol) were added and reaction was stirred 
under the same conditions for an additional hour. The reaction mixture was diluted with 
20 mL of ethyl-acetate and washed with water (3 x 10 mL). The organic layer was dried 
over Na2SO4 concentrated under reduced pressure and subjected to sequential column 
chromatography with dichloromethane methyl tert-butyl ether (20:1) to give product as a 
yellow glassy solid. Yield 167 mg (0.182 mmol, 82%).  
1
H NMR (CDCl3, 400 MHz) δ 
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0.82 (s, 3H), 1.21-1.25 (m, 12H), 1.37 (s, 3H), 2.55 (t, J = 7.37, 7.03 Hz, 4H), 2.92 (s, 
3H), 3.19 (dd, J = 17.51, 5.79, 1H), 3.56 (s, 4H), 3.63 (t, J = 7.48, 7.00 Hz, 4H), 3.86 (dd, 
J = 17.51, 12.22 Hz, 1H), 4.02 (S, 4H), 4.04 (s, 2H), 4.09-4.16 (m, 6H), 5.35 (dd, J = 
12.10, 5.66, 1H), 6.65 (d, J = 8.87 Hz, 2H), 7.08 (d, J = 8.80 Hz, 2H), 7.17 (d, J = 8.92 
Hz, 2H), 7.70 (d, J = 9.16 Hz, 2H), 7.85 (s, 4H). 
13
C NMR (CDCl3, 400 MHz) δ 14.08, 
14.16, 17.28, 19.56, 27.45, 32.40, 33.88, 35.62, 43.32, 46.68, 51.00, 60.65, 61.42, 63.43, 
65.64, 65.70, 72.20, 98.00, 112.81, 112.94, 124.11, 126.28, 126.81, 127.76, 128.33, 
129.57, 136.28, 138.27, 146.62, 147.53, 147.91, 168.35, 171.88. EI HRMS m/z calculated 
for [M
+





A mixture of pyrazoline 5 (100 mg, 0.111 mmol), 1-bromooctane (30 µL, 0.173 mmol) 
and potassium carbonate (31 mg, 0.224 mmol) in 1.0 mL anhydrous acetonitrile was 
stirred in a sealed flask under N2 at 60 °C for 12 hours. After cooling to room 
temperature, the reaction mixture was diluted with 10 mL water and extracted with ethyl-
acetate. The organic layer was dried with Na2SO4, concentrated under reduced pressure, 
and subjected to sequential column chromatography with dichloromethane, hexanes and 
methyl tert-butyl ether (3:3:1). Yield 80 mg (0.079 mmol, 71%). 
1
H NMR (CDCl3, 400 
MHz) δ 0.81 (s, 3H), 0.86 (t, J = 7.12, 6.75, 3H), 1.20-1.25 (m, 24H), 1.37 (s, 3H), 1.53 (t 
br, J = 6.84, 5.91, 2H), 2.55 (t, J = 7.35, 7.07 Hz, 4H), 3.16-3.26 (m, 3H), 3.55 (s, 4H), 
3.63 (t, J = 7.33, 6.95 Hz, 4H), 3.85 (dd, J = 16.88, 12.22 Hz, 1H), 4.03 (s, 2H), 4.08-
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4.14 (m, 8H), 5.34 (dd, J = 12.53, 5.88 Hz, 1H), 6.65 (d, J = 8.84 Hz, 2H), 7.08 (d,J = 
8.84 Hz, 2H), 7.16 (d, J = 9.00 Hz, 2H), 7.70 (d, J = 9.18, 2H), 7.81-7.88 (m, 4H).
13
C 
NMR (CDCl3, 400 MHz) δ 14.07, 14.16, 17.28, 19.57, 22.60, 26.52, 27.48, 27.80, 29.10, 
29.12, 31.71, 32.40, 33.87, 43.34, 46.68, 47.81, 48.25, 60.64, 61.34, 63.40, 65.65, 65.70, 
72.10, 98.00, 112.81, 112.92, 124.03, 126.17, 126.81, 127.73, 128.37, 129.562, 136.056, 
139.82, 146.60, 147.57, 148.03, 168.88, 171.87. EI HRMS m/z calculated for [M
+
] 





A mixture of pyrazoline 5 (100 mg, 0.111 mmol), 1-bromotetradecane (50 µL, 0.166 
mmol) and potassium carbonate (38.5 mg, 0.277 mmol) in 1.0 mL anhydrous acetonitrile 
was stirred in a sealed flask under N2 at 60 °C for 12 hours. 66 µL of 1-bromotetradecane 
was added and reaction was stirred under the same conditions for 15 minutes. After 
cooling to room temperature, the reaction mixture was diluted with 10 mL water and 
extracted with ethyl-acetate. The organic layer was dried with Na2SO4, concentrated 
under reduced pressure, and subjected to sequential column chromatography with 
dichloromethane, hexanes and methyl tert-butyl ether (3:3:1). Yield 99.8 mg (0.091 
mmol, 82%). 
1
H NMR (CDCl3, 400 MHz) δ 0.81 (s, 3H), 0.88 (t, J = 7.03 Hz, 3H), 1.20-
1.25 (m, 34H), 1.37 (s, 3H), 1.53 (t Br, 2H), 2.55 (t, J = 7.25, 7.09 Hz, 4H), 3.16-3.26 (m, 
3H), 3.55 (s, 4H), 3.63 (t, J = 7.25, 7.09 Hz, 4H), 3.85 (dd, J = 17.66, 12.26 Hz, 1H), 4.04 
(s, 2H), 4.08-4.14 (m, 8H), 5.34 (dd, J = 12.26, 5.61 Hz, 1H), 6.64 (d, J = 8.68 Hz, 2H), 
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7.08 (d, J = 8.56 Hz, 2H) 7.16 (d, J = 8.79 Hz, 2H), 7.69 (d, J = 8.88 Hz, 2H), 7.82-7.88 
(m, 4H). 
13
C NMR (CDCl3, 400 MHz) δ 14.07, 14.11, 14.16, 17.27, 19.57, 22.63, 22.66, 
26.54, 27.47, 27.83, 29.17, 29.33, 29.48, 29.52, 29.61, 29.62, 29.66, 31.56, 31.89, 32.40, 
33.87, 43.34, 46.68, 47.81, 48.25, 60.63, 61.33, 63.41, 65.65, 65.70, 72.09, 97.99, 112.82, 
112.92, 124.05, 126.17, 126.81, 127.72, 128.38, 129.55, 136.05, 139.82, 146.61, 147.56, 
148.00, 168.86, 171.85. EI HRMS m/z calculated for [M
+
] C57H84N4O13S2 1096.5476, 
found 1096.5451. 
 
2.5.3 Hydrolysis of protective groups for the formation of derivatives 9-11 
 
Scheme 2.8: Synthesis of pyrazoline derivatives 9-11. 
 
 3,3'-((4-(3-(4-(N-(carboxymethyl)-N-methylsulfamoyl)phenyl)-1-(4-
sulfophenyl)-4,5-dihydro-1H-pyrazol-5-yl)phenyl)azanediyl)dipropanoic acid (9) 
Pyrazoline 6 (50 mg, 0.0546 mmol) was dissolved in a mixture of 90% trifluoroacetic 
acid and 10% H2O (w/w, 2.7 mL) and stirred for 12 minutes at room temperature after 
complete dissolution. The reaction mixture was diluted with H2O (5 mL), stirred for an 
additional 15 minutes, poured into H2O (25 mL), rinsed completely with ethanol (10 mL), 
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cooled by adding crushed ice, and made basic with 28% aqueous ammonia (15mL). The 
resulting suspension was stirred for 30 minutes at 0 °C and the intermediate was then 
collected by extraction with ethyl-acetate, dried with Na2SO4 and concentrated under 
reduced pressure to give yellow oil. The mixture was dissolved in 1.0 mL methanol, 
NaOH was added (122.54 mg, 3.06 mmol to give a concentration of 2M) and the reaction 
was stirred at room temperature under N2 in the dark for 18 hours. The reaction was 
quenched with acetic acid (175 µL, 3.057 mmol) and was subjected for HPLC 
purification (0-40% acetonitrile gradient in 0.1% ammonium bicarbonate H2O over 80 
minutes). Yield 20.5 mg (0.027 mmol, 50%). Product was isolated as the ammonium salt. 
1
H NMR (CDCl3, 400 MHz) δ 2.47 (t, J = 7.45, 7.06 Hz, 4H), 2.81 (s, 3H), 3.13 (dd, J = 
17.72, 6.08 Hz, 1H), 3.59-3.64 (m, 6H), 3.87 (dd, J = 17.00, 12.32 Hz, 1H), 5.42 (dd, J = 
12.22, 6.05 Hz, 1H), 6.71 (d, J = 8.79 Hz, 2H), 7.09 (d, J = 8.76 Hz, 2H), 7.12 (d, J = 
9.04 Hz, 2H), 7.61 (d, J = 9.02 Hz, 2H), 7.82 (d, J = 8.79, 2H), 7.93 (d, J = 8.69, 2H). 
13
C 
NMR (CDCl3, 400 MHz) δ 32.50, 34.91, 42.56, 46.89, 48.43, 63.67, 112.45, 112.70, 
125.82, 126.48, 126.66, 127.46, 129.42, 135.02, 136.92, 136.98, 145.44, 146.56, 146.64, 
173.11, 175.34. EI HRMS m/z calculated for [M+H
+




sulfophenyl)-4,5-dihydro-1H-pyrazol-5-yl)phenyl)azanediyl)dipropanoic acid (10) 
Pyrazoline 7 (145 mg, 0.143 mmol) was dissolved in a mixture of 90% trifluoroacetic 
acid and 10% H2O (w/w, 5.28 mL) and stirred for 12 minutes at room temperature after 
complete dissolution. The reaction mixture was diluted with H2O (5 mL), stirred for an 
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additional 15 minutes, poured into H2O (25 mL), rinsed completely with ethanol (10 mL), 
cooled by adding crushed ice, and made basic with 28% aqueous ammonia (7.16 mL). 
The resulting suspension was stirred for 30 minutes at 0 °C and the intermediate was then 
collected by extraction with ethyl-acetate, dried with Na2SO4 and concentrated under 
reduced pressure to give yellow oil. The mixture was dissolved in 4.0 mL methanol, 
NaOH was added (320 mg, 8 mmol, to give a concentration of 2M) and the reaction was 
stirred at room temperature under N2 in the dark for 18 hours. The reaction was quenched 
with acetic acid (495 µL, 8.64 mmol) and was subjected for HPLC purification (0-40% 
acetonitrile gradient in 0.1% ammonium bicarbonate H2O over 80 minutes). Yield 42 mg 
(0.049 mmol, 62.7% after recovery of starting material). Product was isolated as the 
ammonium salt. 
1
H NMR (CDCl3, 400 MHz) δ 0.85 (t, J = 7.15, 6.89 Hz, 3H), 1.15-1.29 
(m, 10H), 1.43-1.50 (m, 2H), 2.46 (t, J = 7.21 Hz, 4H), 3.10 (dd, J = 17.64, 6.07 Hz, 1H), 
3.27 (t, J = 7.70, 7.54 Hz, 2H), 3.61 (t, J = 7.33, 7.00 Hz, 4H), 3.81-3.88 (m, 3H), 5.39 
(dd, J = 12.33, 5.94 Hz, 1H), 6.71 (d, J = 8.68 Hz, 2H), 7.07 (d, J = 8.57 Hz, 2H), 7.11 
(d, J = 8.98 Hz, 2H), 7.61 (d, J = 8.94 Hz, 2H), 7.84-7.90 (m, 4H). 
13
C NMR (CDCl3, 
400 MHz) δ 13.08, 20.28, 22.30, 26.40, 27.10, 28.85, 28.88, 31.51, 33.15, 42.61, 46.97, 
47.13, 47.18, 47.40, 42.61, 47.13, 47.90, 48.10, 48.46, 63.60, 112.44, 112.55, 125.74, 
126.47, 126.64, 127.30, 129.18, 134.84, 136.61, 139.62, 145.47, 146.64, 146.68, 174.01, 
176.27. EI HRMS m/z calculated for [M
+
] C37H47N4O11S2 787.2786, found 787.2683. 
 
3,3'-((4-(3-(4-(N-(carboxymethyl)-N-tetradecylsulfamoyl)phenyl)-1-(4-
sulfophenyl)-4,5-dihydro-1H-pyrazol-5-yl)phenyl)azanediyl)dipropanoic acid (11) 
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Pyrazoline 8 (166 mg, 0.151 mmol) was dissolved in a mixture of 90% trifluoroacetic 
acid and 10% H2O (w/w, 5.28 mL) and stirred for 12 minutes at room temperature after 
complete dissolution. The reaction mixture was diluted with H2O (5 mL), stirred for an 
additional 15 minutes, poured into H2O (25 mL), rinsed completely with ethanol (10 mL), 
cooled by adding crushed ice, and made basic with 28% aqueous ammonia (7.16 mL). 
The resulting suspension was stirred for 30 minutes at 0 °C and the intermediate was then 
collected by extraction with ethyl-acetate, dried with Na2SO4 and concentrated under 
reduced pressure to give yellow oil. The mixture was dissolved in 4.0 mL methanol, 
NaOH was added (320 mg, 8 mmol, to give a concentration of 2M) and the reaction was 
stirred at room temperature under N2 in the dark for 18 hours. The reaction was quenched 
with acetic acid (495 µL, 8.64 mmol) and was subjected for HPLC purification (20-40% 
acetonitrile gradient over in 0.1% ammonium bicarbonate H2O over 20 minutes and then 
40-70% over 12 minutes). Yield 36.6mg (0.038 mmol, 28.6% after recovery of starting 
material). Product was isolated as the ammonium salt. 
1
H NMR (CDCl3, 400 MHz) δ 
0.89 (t, J = 7.02, 6.74 Hz, 3H), 1.21-1.25 (m, 22H), 1.48 (t br, J = 6.97, 6.87 Hz, 2H), 
2.48 (t, J = 7.37, 7.17 Hz, 4H), 3.11 (dd, J = 17.60, 6.05 Hz, 1H), 3.27 (t, J = 7.73, 7.58 
Hz, 2H), 3.61 (t, J = 7.32, 7.02 Hz, 4H), 3.82-3.89 (m, 3H), 5.40 (dd, J = 12.41, 6.00 Hz, 
1H), 6.70 (d, J = 8.75 Hz, 2H), 7.08 (d, J = 8.79 Hz, 2H), 7.11 (d, J = 8.93 Hz, 2H), 7.61 
(d, J = 8.90 Hz, 2H), 7.84-7.90 (m, 4H). 
13
C NMR (CDCl3, 400 MHz) δ 13.07, 22.33, 
26.37, 27.13, 28.86, 29.06, 29.19, 29.24, 29.35, 29.39, 31.66, 32.85, 42.62, 47.02, 47.67, 
47.88, 48.07, 48.44, 63.63, 112.43, 112.58, 125.72, 126.48, 126.65, 127.31, 129.27, 
134.90, 136.63, 139.60, 145.45, 146.60, 146.65, 173.77, 175.80. EI HRMS m/z calculated 
for [M
+
] C43H59N4O11S2 871.3674, found 871.3622. 
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2.5.4 pKa measurements and Quantum yield determination 
pKa measurements: Fluorescence spectra and UV-vis absorption spectra were 
acquired in 0.1 M KCl as ionic background in 1 mM PIPES, 1 mM PIPBS (pH 8.5). The 
excitation wavelength was set at 380 nm and the emission scan ranged from 390–700 nm 
and 250-500 nm respectively. All solutions were filtered through 0.2 µm membrane 
filters to remove interfering dust particles or fibers. Three independent pKa titrations were 
carried out at 7.06 µM concentration of compound 9 by adding HCl such that pH interval 
is 0.24 at each step. The data were analyzed by non-linear least-squares fitting using the 
Specfit software package
6
. pH ranges between 8.5 to 4.18. 
 
Quantum Yields and Fluorescence Enhancement Factors: Quantum yield of 
compound 9 and fluorescence enhancement factor was determined in 0.1 M KCl, 10 mM 
MOPS buffer (pH 7.2), which had been filtered through a 0 45 μM membrane filter to 
remove dust particles. For quantum yield determination, excitation was at 380 nm and 
four data points with absorbances between 0.1 and 0.5 (l = 10 cm) were used. 
Norharmane was used as a standard with a known quantum yield of 58% in 0.1 M H2SO4. 
Equation 4.1 was used for a one point quantum yield determination in the case of 
liposome studies. 











              
Where Φx is the quantum yield of the unknown, Φs is the quantum yield of the standard, 
Ax is the optical density of the unknown, As is the optical density of the standard, Ix is the 
fluorescence intensity of the unknown, Is is the fluorescence intensity of the standard and 
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nx is the refractive index of the medium of the unknown and ns is the refractive index of 
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Ethyl 2-(4-acetylphenylsulfonamideo)acetate (1) 
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Diehtyl 3,3'-((4-formylphenyl)azanediyl)dipropanoate (3) 
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dihydro-1H-pyrazol-5-yl)phenyl)azanediyl)dipropanoic acid (9) 
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dihydro-1H-pyrazol-5-yl)phenyl)azanediyl)dipropanoic acid (10) 
1
H NMR (CD3OD, 400 MHz) 
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4,5-dihydro-1H-pyrazol-5-yl)phenyl)azanediyl)dipropanoic acid (11) 
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LIPOSOME STUDIES AND DISCUSSION 
 
3.1 Introduction 
In 1972, Singer and Nicolson proposed the fluid mosaic model for characterizing 
the properties of biological membranes.
1
 According to this model, biological membranes 
are analogous to a two-dimensional solution of proteins integrated within the viscous 
phospholipid bilayer solvent. Studies conducted around that time also showed that 
liposomes composed of phospholipids retained some of the main properties of biological 
membranes.
2
 Since then, liposomes have been established as a versatile model system for 
studying the interactions between organic molecules and lipid bilayers. It is important to 
keep in mind that a system only composed of phospholipids is a greatly simplified 
representation of a biological membrane; nevertheless, it has been shown that liposomes 
containing cholesterol and a combination of structurally different phospholipids can 




The goal of this study was to investigate the effect of membrane proximity on the 
kinetics of the PET process of 1,3,5-triarylpyrazoline based fluorescence “turn-on” 
probes. Because a decrease in the PET kinetics results in a quantum yield increase, the 
photophysical properties provide a direct readout to gauge changes in the PET kinetics. 
Hence, fluorescence emission spectra and quantum yield measurements of pyrazolines 9-
11 have been conducted in free aqueous buffer and in the presence of neutral and anionic 
liposomes as listed in Table 3.1.  
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9 CH3 503 503 501 
 
0.021 0.021 0.021 
10 C8H17 500 500 498 
 
0.023 0.024 0.023 




Samples were excited at 380 nm and emission was acquired over the range of 390-700 nm.
 
c
Quantum yield calculated based on a one point measurement compared to standard Norharmane in 0.1N H2SO4 




 pH 7.2. 
 
 
3.2 Liposome Studies 
 To study the effects of membrane proximity on the kinetics of the PET 
processes of 1,3,5 triarylpyrazoline based fluorescence probes, neutral liposomes 
composed of 1,2-dimyrisotyl-sn-glycero-3-phosphocholine and anionic liposomes 
composed of 1,2-dimyrisotyl-sn-glycero-3-phospho-(1‟-rac-glycerol) as sodium salt, 
were used. Each sample contained 10 µM of the fluorescent probe and 200 µM of the 
lipid. Liposomes were created by the extrusion technique.
3b, 4
 Briefly, the respective 
probe and the lipids were first combined in an organic solvent. After evaporating the 
solvent under reduced pressure, the solid residue was dried under high vacuum for 3 
hours and then hydrated (swelled) by addition of 10 mM MOPS/K
+
 buffer (pH 7.2). Each 
sample was vortexed to disperse the lipids and to form multilamellar vesicles. Finally, the 
multilamellar vesicles were extruded through a polycarbonate filter (pore size 100 nm) to 




3.2.1 Neutral Liposomes 
Fluorescence emission spectra were acquired for pyrazolines 9-11 in the presence 
and absence of neutral liposomes as shown in Figure 3.1A-C. Pyrazolines 9 and 10, 
containing a methyl and octyl group on the 3-aryl sulfonamide, respectively, exhibit 
neither changes in their fluorescence emission maximum nor the quantum yields (Figure 
3.1 A and B). This result is expected for pyrazoline 9 since most likely an addition of one 
carbon cannot contribute enough lipophilic character to yield a favorable interaction with 
the liposome membrane. In case of pyrazoline 10, it appears that even an 8-carbon alkyl 
chain does not provide sufficient lipophilicity for interacting with the neutral liposomes. 
Pyrazoline 11, perhaps most surprisingly, showed neither an increase of the fluorescence 
intensity nor quantum yield as can be seen in Figure 3.1C; however, the peak emission 
wavelength shifted to higher energy from 495 nm to 481 nm, indicating some interaction 





Figure 3.1: Fluorescence emission spectra of compounds 9-11 in presence and absence of neutral 
liposomes. Samples were excited at 380 nm and fluorescence emission was acquired over the range of 390-
700 nm. Each sample containing 10 µM probe and 200 µM lipids was hydrated with a 10 mM MOPS/K
+
 
buffer (pH 7.2). Liposomes were made by an extrusion technique to give large unilamellar vesicles with an 
average diameter of 100 nm. All measurements were conducted at room temperature. Emission spectra 
were compared to the respective compound in 10 mM MOPS/K
+
 buffer (pH 7.2).  A. Fluorescence 
emission spectrum of pyrazoline 9. B. Fluorescence emission spectrum of pyrazoline 10. C. Fluorescence 




3.2.2 Anionic liposomes 
 Fluorescence emission spectra were acquired for pyrazolines 9-11 in the 
presence and absence of anionic liposomes as shown in Figure 3.2 A-C. Analogous to the 
behavior in the presence of neutral liposomes, pyrazolines 9 and 10 exhibit again neither 
changes in their fluorescence emission intensity nor their quantum yields (Figure 3.2A 
and B). This result is expected since there is repulsion between the overall anionic charge 
on the pyrazoline and the anionic phospholipids. In contrast, pyrazoline 11 showed, 
within experimental error, also no changes in the emission maximum (Figure 3.2C), 
presumably due to the unfavorable electrostatic repulsion of the polyanionic probe and 





Figure 3.2: Fluorescence emission spectra of compounds 9-11 in presence and absence of anionic 
liposomes. Samples were excited at 380 nm and fluorescence emission was acquired over the range of 390-
700 nm. Each sample containing 10 µM probe and 200 µM lipids was hydrated with a 10 mM MOPS/K
+
 
buffer (pH 7.2). Liposomes were made by an extrusion technique to give large unilamellar vesicles with an 
average diameter of 100 nm. All measurements were conducted at room temperature. Emission spectra 
were compared to the respective compound in 10 mM MOPS/K
+
 buffer (pH 7.2). A. Fluorescence emission 
spectrum of pyrazoline 9. B. Fluorescence emission spectrum of pyrazoline 10. C. Fluorescence emission 




Pyrazolines 9-11 carry a net tetra-anionic charge, and, as outlined in the 
introduction to Chapter 2, the interaction with liposomes was expected to occur only 
through the alkylated sulfonamide moiety located on the 3-aryl ring. Upon equilibration 
of the probes with liposomal membranes, the polarity of the environment surrounding the 
probes was expected to change, due to increase in alkyl chain lengths, which should have 
resulted in differences in fluorescence intensity and quantum yield among the probes.  
In summary, the results shown in Table 3.1, Figure 3.1 and Figure 3.2 indicate 
that membrane proximity had no significant effect on the fluorescence intensity or the 
quantum yields of pyrazolines 9-11, a result that is surprisingly different from the initial 
observation made with CTAP-2. In view of the minor photophysical changes upon 
membrane anchoring, it should be therefore possible to design PET probes that 
selectively localize in biological membranes, for example in mitochondria or the Golgi 
apparatus, without suffering from environmentally dependent changes. Anchoring the 
probe in such a manner could then provide direct insights into the presence of specific 
analytes in these subcellular locations.   
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3.4 Future Directions 
 The results described above indicate that membrane proximity has negligible 
effect on the quantum yields and fluorescence intensities of pyrazolines 9-11. To further 
characterize the effect of biological membranes on PET, perhaps a more complex 
composition of liposomes is required. Biological membranes are composed of three 
different types of amphipathic lipids; phospholipids, glycolipids and cholesterol. With 
regard to phospholipids, the chain length of the lipid tail may range from16 to 20 carbon 
atoms and the degree of saturation may further affect the physical properties of the 
membrane, mainly by changing its transition temperature which affects the fluidity of the 
lipid bilayer. Several studies were reported that describe the effect of cholesterol on 
membrane composition in liposomes, and the membrane structure indeed does become 
more complex, showing the presence of lipid rafts like regions along with liquid 
disordered and liquid ordered regions.
3b, 4
  
 The study presented herein is based on the interaction between pyrazolines 9-11 
with liposomes as a function of different alkyl chain lengths. As explained above, the cell 
permeability experiment could not show a clear interaction between the compounds and 
the cells, though it is not clear to what extent the probes remained quenched and therefore 
not observable after cellular uptake  To ensure such interactions, a fluorescence “turn-on” 
probe could be linked either to the phospholipid head group or to its tail group. The latter 
could be achieved by click chemistry. A study conducted by Usoh et al.
5
 modified a 
phospholipid tail by attaching an azide group to it. To investigate how the PET process is 
influenced by membrane embedment the pyrazoline could be utilized with an azide group 




Scheme 3.1: Retrosynthetic analysis of a pyrazoline conjugated to a phospholipid. 
 
In order to attach the probe to a phospholipid head group, a more sophisticated 
scheme is required. Several studies were conducted on attaching either a quenching 
moiety or a cargo moiety to a phospholipid.
6
 Based on those studies, one way of 
attaching a pyrazoline probe to a phospholipid head group is by modifying a carboxylic 
acid group with an N-hydroxy succinimide activated ester, which would then be 
substituted by the phosphate group on the phospholipid. A retrosynthetic analysis for this 






Scheme 3.2: Retrosynthetic analysis of a pyrazoline conjugated via head group of a phospholipid. 
 
3.5 Material and methods 
General: UV-vis absorption spectra were acquired at 22 °C with a Varian Cary 
Bio50 spectrophotometer with constant temperature accessory. Fluorescence spectra were 
recorded with a PTI fluorimeter. The fluorescence spectra were corrected for the spectral 
response of the detection system and for the spectral irradiance of the excitation source 
(via a calibrated photodiode). The path length was 1 cm for absorbance and fluorescence 







3.5.1 Fluorescence absorbance and emission measurements 
 Fluorescence spectra were acquired with excitation at 380 nm and measured over 
the emission range of 390-700 nm, and the UV-vis absorbance was measured over the 
range of 250-500 nm. 
 
3.5.2 Quantum Yields and Fluorescence Enhancement Factors 
 Quantum yield of compound 9 and fluorescence enhancement factor was 
determined in 0.1 M KCl, 10 mM MOPS buffer (pH 7.2), which had been filtered 
through a 0 45 μM membrane filter to remove dust particles. For quantum yield 
determination, excitation was at 380 nm and four data points with absorbances between 
0.1 and 0.5 (l = 10 cm) were used. Norharmane was used as a standard with a known 
quantum yield of 58% in 0.1 M H2SO4. Equation 4.1 was used for a one point quantum 
yield determination in the case of liposome studies. 











              
Where Φx is the quantum yield of the unknown, Φs is the quantum yield of the standard, 
Ax is the optical density of the unknown, As is the optical density of the standard, Ix is the 
fluorescence intensity of the unknown, Is is the fluorescence intensity of the standard and 
nx is the refractive index of the medium of the unknown and ns is the refractive index of 
the medium of the standard. 
 
3.5.3 Liposome sample preparation
2
 
All experiments were done using large unilamellar vesicles of 100 nm diameter of 
the appropriate phospholipids. All concentrations were adjusted for 3 mL final volume 
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and each sample contained 200 µM of lipids and 10 µM of compound. To each sample 
60 µL of phospholipids (0.4 mg, 0.59 µmol for 1,2-dimyrisotyl-sn-glycero-3-
phosphocholine and 0.4 mg, 0.58 µmol for 1,2-dimyrisotyl-sn-glycero-3-phospho-(1‟-
rac-glycero) sodium salt in chloroform was mixed with the appropriate volume of the 
compound in methanol. After drying the mixture first under a stream of N2 and then 
under a high vacuum for 3 hours, it was hydrated (swelled) by adding 3.0 mL of 10 mM 
MOPS, 0.1 M KCl, pH 7.2 buffer and vortexed for 3 minutes to disperse the lipid and 
form homogeneous multilamellar vesicles. Large unilamellar vesicles were then prepared 
by extrusion technique. Briefly, the multilamellar vesicles were extruded through 
polycarbonate filters (pore diameter 100 nm) mounted in the extruder fitted with 
Hamilton syringes (Hamilton company, Reno, NV). The samples were subjected to 17 
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